Form 4: Accenture General Counsel Joel Unruch Disposes of Class A Ordinary Shares Under 10b5-1 Trading Plan
SEC Form 4
Accenture's General Counsel, Joel Unruch, executed sales of Class A ordinary shares on January 24, 2025, under a pre-arranged Rule 10b5-1 trading plan.
Summary
- On January 24, 2025, Joel Unruch, General Counsel and Corporate Secretary of Accenture plc, disposed of Class A ordinary shares.
- The sales were executed under a Rule 10b5-1 trading plan.
- A total of 695 shares were sold at a weighted average price of $361.2549, with individual trades ranging from $360.77 to $361.67.
- Another 772 shares were sold at a weighted average price of $362.4901, with individual trades ranging from $361.795 to $362.725.
- Finally, 3,283 shares were sold at a weighted average price of $363.1649, with individual trades ranging from $362.83 to $363.805.
- Following these transactions, Unruch still beneficially owns 20,526 Class A ordinary shares.
Sentiment
Score: 6
Explanation: The document is neutral. It reports transactions under a pre-arranged trading plan, which is a normal course of business. There is no indication of positive or negative sentiment.
Positives
- The sales were executed under a pre-arranged Rule 10b5-1 trading plan, which is a legal and transparent way for insiders to sell shares.
Industry Context
Sales by corporate insiders are common and are often viewed in the context of their trading plans and overall holdings. Rule 10b5-1 plans are designed to allow insiders to sell shares without being accused of trading on non-public information.
Comparison to Industry Standards
- Comparing Unruch's transactions to similar filings by executives at comparable consulting firms like Deloitte, McKinsey, or Boston Consulting Group would provide context.
- Analyzing the frequency and size of insider sales at these firms could reveal whether Unruch's activity is typical or unusual.
- Benchmarking the use of 10b5-1 plans among these companies would also be relevant.
Stakeholder Impact
- The sale of shares by a high-ranking executive could be perceived negatively by some shareholders, but the existence of a 10b5-1 plan mitigates this concern.
Key Dates
| Date | Description |
|---|---|
| 01/24/2025 | Date of the transactions (sale of Class A ordinary shares) |
| 01/27/2025 | Date of signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.